(Q34554406)

3 August 2017

title

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis (English)

1 reference

3 August 2017

0 references

1 reference

placebo-controlled trial

1 reference

Arata Azuma

1 reference

3 August 2017

Toshihiro Nukiwa

1 reference

3 August 2017

Eiyasu Tsuboi

1 reference

3 August 2017

Moritaka Suga

1 reference

3 August 2017

Shosaku Abe

1 reference

3 August 2017

Koichiro Nakata

1 reference

3 August 2017

Yoshio Taguchi

1 reference

3 August 2017

Sonoko Nagai

1 reference

3 August 2017

Harumi Itoh

1 reference

3 August 2017

Motoharu Ohi

1 reference

3 August 2017

Atsuhiko Sato

1 reference

3 August 2017

Shoji Kudoh

1 reference

3 August 2017

language of work or name

English

0 references

publication date

21 January 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

3 August 2017

published in

1 reference

3 August 2017

volume

171

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

1040-1047

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

3 August 2017

1 reference

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

Reliability and validity of the chronic respiratory questionnaire (CRQ).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

Assessment of health-related quality of life in patients with interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-2002. A 56-year-old man with rapidly worsening dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-571OC

10.1164/RCCM.200404-571OC

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference